Ipsen Pharma: Ipsen completes acquisition of Kartos Therapeutics, strengthening late-stage Oncology pipeline

PARIS, FRANCE, 21 AUGUST 2026 - Ipsen (Euronext: IPN; ADR: IPSEY) announced today it has completed the acquisition of Kartos Therapeutics, a clinical-stage biopharmaceutical company adding late-sta...